Quinolone antimicrobial agents.

This chapter reviews the chemistry, microbiology, pharmacology, and clinical use of the fluoroquinolone antimicrobial agents. The molecular and clinical problems of bacterial resistance are reviewed. The clinical areas in which fluoroquinolones have been investigated are detailed, with particular attention to areas of appropriate and inappropriate use.

[1]  P. M. Terry,et al.  Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. , 1991, The Journal of infectious diseases.

[2]  S. Nakamura,et al.  Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli , 1990, Antimicrobial Agents and Chemotherapy.

[3]  R. Lang,et al.  Successful treatment of malignant external otitis with oral ciprofloxacin: report of experience with 23 patients. , 1990, The Journal of infectious diseases.

[4]  H. K. Das,et al.  Cloning and sequence analysis of gyrA gene of Klebsiella pneumoniae , 1990, Nucleic Acids Res..

[5]  M. F. Parry,et al.  Quinolone resistance. Susceptibility data from a 300-bed community hospital. , 1989, The American journal of medicine.

[6]  J. Bosso.  Use of ciprofloxacin in cystic fibrosis patients. , 1989, The American journal of medicine.

[7]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents , 1989, Clinical Microbiology Reviews.

[8]  K. Ubukata,et al.  Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus , 1989, Antimicrobial Agents and Chemotherapy.

[9]  J. Pechère,et al.  Laboratory survey of fluoroquinolone activity. , 1989, Reviews of infectious diseases.

[10]  L. Peterson,et al.  Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. , 1989, The American journal of medicine.

[11]  A. Wyke,et al.  Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones , 1989, Antimicrobial Agents and Chemotherapy.

[12]  S. Mitsuhashi,et al.  Quinolone resistance in clinical isolates of Serratia marcescens , 1989, Antimicrobial Agents and Chemotherapy.

[13]  S. Schaefler.  Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones , 1989, Journal of clinical microbiology.

[14]  T. Hooton,et al.  Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method , 1989, Antimicrobial Agents and Chemotherapy.

[15]  S. Mitsuhashi,et al.  Clinical isolate of Citrobacter freundii highly resistant to new quinolones , 1988, Antimicrobial Agents and Chemotherapy.

[16]  N. Georgopapadakou,et al.  Routes of quinolone permeation in Escherichia coli , 1988, Antimicrobial Agents and Chemotherapy.

[17]  J. Wang,et al.  DNA gyrase and its complexes with DNA: direct observation by electron microscopy , 1985, Cell.

[18]  K. Drlica,et al.  Biology of bacterial deoxyribonucleic acid topoisomerases. , 1984, Microbiological reviews.

[19]  L. Mitscher,et al.  Structure-Activity Relationships of Fluoro-4-Quinolones , 1990 .

[20]  H. Neu.  Bacterial resistance to fluoroquinolones. , 1988, Reviews of infectious diseases.

[21]  B. Ulbrich,et al.  Specific toxicologic aspects of the quinolones. , 1988, Reviews of infectious diseases.